KR910000177A - 가금 마이코플라즈마 항원 및 그 유전자를 함유한 재조합벡타, 및 그를 이용한 진단제 및 백신 - Google Patents
가금 마이코플라즈마 항원 및 그 유전자를 함유한 재조합벡타, 및 그를 이용한 진단제 및 백신 Download PDFInfo
- Publication number
- KR910000177A KR910000177A KR1019890007621A KR890007621A KR910000177A KR 910000177 A KR910000177 A KR 910000177A KR 1019890007621 A KR1019890007621 A KR 1019890007621A KR 890007621 A KR890007621 A KR 890007621A KR 910000177 A KR910000177 A KR 910000177A
- Authority
- KR
- South Korea
- Prior art keywords
- polypeptide
- amino acid
- acid sequence
- dna fragment
- mycoplasma
- Prior art date
Links
- 241000204031 Mycoplasma Species 0.000 title claims 6
- 244000144977 poultry Species 0.000 title claims 5
- 229960005486 vaccine Drugs 0.000 title claims 3
- 229940039227 diagnostic agent Drugs 0.000 title claims 2
- 239000000032 diagnostic agent Substances 0.000 title claims 2
- 108090000623 proteins and genes Proteins 0.000 title description 2
- 239000000427 antigen Substances 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 claims 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 239000012634 fragment Substances 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 108090000204 Dipeptidase 1 Proteins 0.000 claims 1
- 230000002725 anti-mycoplasma Effects 0.000 claims 1
- 102000005936 beta-Galactosidase Human genes 0.000 claims 1
- 108010005774 beta-Galactosidase Proteins 0.000 claims 1
- 102000006635 beta-lactamase Human genes 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 108091008146 restriction endonucleases Proteins 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제4도, 제5도 및 제6도는 본 발명에 따르는 항원 단백질 플라즈미드를 제조하는 과정을 나타내는 것이다.
Claims (16)
- 항원-항체 반응에 의해 항-마이코플라즈마 갈리셉티쿰(Mychplasma gallisepticum) 가금 혈청과 반응할 수 있는 폴리펩티드.
- 제1항에 있어서, 폴리펩티드가 MG-1, MG-2, MG-3, MG-4, MG-5, MG-6, MG-7, MG-8, MG-9, MG-10, MG-11, MG-12, MG-13, MG-14, MG-15, MG-16, MG-17, MG-18, MG-19, MG-20, MG-21 또는 MG-22, 또는 이러한 폴리펩티드와 실제로 동일한 작용을 갖는 폴리펩티드인 폴리펩티드.
- 제2항에 있어서, 폴리펩티드가 그의 아미노산 서열이 제1(a)-1도 및 제1(a)-2도에 기재된 MG-1, 의 아미노산 서열이 제1(b)도에 기재된 MG-2, 그의 아미노산 서열이 제1(c)도에 기재된 MG-3, 그의 아미노산 서열이 제1(d)도에 기재된 MG-4, 그의 아미노산 서열이 제1(c)도에 기재된 MG-5, 또는 그의 아미노산 서열이 제1(f)-1도 및 제1(f)-2도에 기재된 MG-6인 폴리펩티드.
- 제1항에 있어서, 폴리펩티드가 실제로 마이코플라즈마 갈리셉티쿰에서 발현되는 폴리펩티드와 동일한 아미노산 서열을 지니며, 그 아미노산 서열이 제2항 또는 제3항의 폴리펩티드의 아미노산 서열을 포함하는 폴리펩티드.
- 제4항에 있어서, 폴리펩티드가 제2도에 기재된 아미노산 서열을 갖는 TMG-1인 폴리펩티드.
- 제1항에 있어서, 폴리펩티드가 그의 C-말단이 MG-1, MG-2, MG-3, MG-4, MG-5, MG-6, MG-7, MG-8, MG-9, MG-10, MG-11, MG-12, MG-13, MG-14, MG-15, MG-16, MG-17, MG-18, MG-19, MG-20, MG-21 또는 MG-22이며 그의 N-말단이 세균으로부터 유래된 효소 단백질인 융합된 단백질인 폴리펩티드.
- 제6항에 있어서, 세균으로부터 유래된 효소 단백질이 β-갈락토시다제 또는 β-락타마제인 폴리펩티드.
- 제1항 내지 제5항중 어느 한 항에 따른 폴리펩티드를 코우딩하는 DNA 절편.
- 제8항에 있어서, 제3(a) 내지 (v)도 중 어느 하나에서 나타낸 제한 효소 부위 지도 및 길이를 갖는 마이코플라즈마 갈리셉티쿰으로부터 유래된 DNA 절편.
- 제8항에 있어서, 염기 서열이 제1(a)-1도 내지 제1(f)-2도에 기재된 서열로부터 선택된 DNA 절편.
- 제8항에 있어서, 염기 서열이 제2도에 기재된 DNA 절편.
- 제8항 내지 제11항중 어느 한 항에 따른 DNA 절편이 삽입된 재조합 벨타.
- 제12항의 재조합 벡타에 의해 형질 전환된 숙주.
- 제1항 내지 제7항중 어느 한 항에 따른 폴리펩티드를 유효성분으로 함유하는, 마이코플라즈마 갈리셉티쿰 감염에 대한 가금 진단제.
- 제1항 내지 제7항중 어느 한 항에 따른 폴리펩티드를 유효 성분으로 함유하는, 마이코플라즈마 갈리셉티쿰감염에 대한 가금 백신.
- 제15항에 있어서, 폴리펩티드가 MG-1으로부터 선택된 것으로, MG-1 및 TMG-1과 실제로 동일한 작용을 갖는 폴리펩티드인, 마이코플라즈마 갈리셉티쿰 감염에 대한 가금 백신.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13634388 | 1988-06-02 | ||
JP63-136343 | 1988-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR910000177A true KR910000177A (ko) | 1991-01-29 |
Family
ID=15172983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890007621A KR910000177A (ko) | 1988-06-02 | 1989-06-02 | 가금 마이코플라즈마 항원 및 그 유전자를 함유한 재조합벡타, 및 그를 이용한 진단제 및 백신 |
Country Status (7)
Country | Link |
---|---|
US (2) | US5621076A (ko) |
EP (1) | EP0345021B1 (ko) |
JP (1) | JP2670145B2 (ko) |
KR (1) | KR910000177A (ko) |
AU (1) | AU623657B2 (ko) |
CA (1) | CA1339260C (ko) |
DE (1) | DE68914883T2 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5338543A (en) * | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
USRE39494E1 (en) * | 1992-02-27 | 2007-02-27 | Intervet Inc. | Inactivated mycoplasma hyopneumoniae and uses therefor |
JP3372952B2 (ja) * | 1992-05-29 | 2003-02-04 | 日本ゼオン株式会社 | 家禽マイコプラズマ抗原、その遺伝子、その遺伝子を含む組み換えベクター、およびそれを利用したワクチン |
US5871742A (en) * | 1993-03-31 | 1999-02-16 | Nippon Zeon Co., Ltd | Recombinant Avipox virus encoding polypeptide of mycoplasma gallisepticum, and utilized a live vaccine |
AU2176997A (en) * | 1996-03-29 | 1997-10-22 | Nippon Zeon Co., Ltd. | Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
ZA9710606B (en) * | 1996-12-05 | 1998-06-12 | Akzo Nobel Nv | Non-virulent Mycoplasma synoviae vaccine thereof. |
EP0846468B1 (en) * | 1996-12-05 | 2004-06-09 | Akzo Nobel N.V. | Non-virulent mycoplasma synoviae and vaccine thereof |
WO1999014317A1 (en) * | 1997-09-19 | 1999-03-25 | Synbiotics Corporation | Methods for the diagnosis of feline infectious anemia |
US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
US20070003508A1 (en) | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
US6936707B2 (en) | 2001-07-11 | 2005-08-30 | Zeon Corporation | Modified DNA molecule, recombinant containing the same, and uses thereof |
US20030059799A1 (en) * | 2001-07-11 | 2003-03-27 | Takashi Okuda | Modified DNA molecule, recombinant containing the same, and uses thereof |
US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
WO2005091967A2 (en) * | 2004-03-03 | 2005-10-06 | University Of Georgia Research Foundation, Inc. | Methods and compositions for ophthalmic treatment of fungal and bacterial infections |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5910192A (ja) * | 1982-07-06 | 1984-01-19 | Mitsubishi Motors Corp | 直流モータの駆動制御装置 |
US4894332A (en) * | 1985-03-27 | 1990-01-16 | Biogen, Inc. | DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins |
ATE135048T1 (de) * | 1986-07-25 | 1996-03-15 | Synergen Inc | Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben |
JPH02500327A (ja) * | 1986-09-08 | 1990-02-08 | アプライド バイオテクノロジー,インコーポレーテッド | マイコバクテリアに対する遺伝子操作ワクチン |
AU1548388A (en) * | 1987-02-02 | 1988-08-24 | Whitehead Institute For Biomedical Research | Mycobacterium tuberculosis genes and encoding protein antigens |
GB8709803D0 (en) * | 1987-04-24 | 1987-05-28 | Mcfadden J J | Treatment of crohn's disease &c |
DE3881993T2 (de) * | 1987-09-18 | 1993-09-30 | Akzo Nv | Mycoplasma-Impfstoff. |
US5196514A (en) * | 1990-03-06 | 1993-03-23 | The University Of Georgia Research Foundation, Inc. | Method of detecting mycoplasma infection in poultry and compositions therefor |
JP3372952B2 (ja) * | 1992-05-29 | 2003-02-04 | 日本ゼオン株式会社 | 家禽マイコプラズマ抗原、その遺伝子、その遺伝子を含む組み換えベクター、およびそれを利用したワクチン |
-
1989
- 1989-05-31 DE DE68914883T patent/DE68914883T2/de not_active Expired - Fee Related
- 1989-05-31 EP EP89305441A patent/EP0345021B1/en not_active Expired - Lifetime
- 1989-05-31 CA CA000601326A patent/CA1339260C/en not_active Expired - Fee Related
- 1989-06-01 AU AU35940/89A patent/AU623657B2/en not_active Ceased
- 1989-06-02 JP JP1140283A patent/JP2670145B2/ja not_active Expired - Fee Related
- 1989-06-02 KR KR1019890007621A patent/KR910000177A/ko not_active Application Discontinuation
-
1994
- 1994-09-02 US US08/299,662 patent/US5621076A/en not_active Expired - Lifetime
-
1997
- 1997-01-02 US US08/775,878 patent/US5766594A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE68914883T2 (de) | 1994-08-18 |
US5621076A (en) | 1997-04-15 |
JP2670145B2 (ja) | 1997-10-29 |
US5766594A (en) | 1998-06-16 |
EP0345021B1 (en) | 1994-04-27 |
EP0345021A3 (en) | 1990-04-18 |
EP0345021A2 (en) | 1989-12-06 |
AU3594089A (en) | 1989-12-07 |
CA1339260C (en) | 1997-08-12 |
DE68914883D1 (de) | 1994-06-01 |
JPH02111795A (ja) | 1990-04-24 |
AU623657B2 (en) | 1992-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910000177A (ko) | 가금 마이코플라즈마 항원 및 그 유전자를 함유한 재조합벡타, 및 그를 이용한 진단제 및 백신 | |
BR9916020A (pt) | Compostos e métodos para o tratamento e diagnóstico de infecção por chlamydia | |
BR9712518A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico | |
NO20070618L (no) | Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose. | |
BRPI0208301B8 (pt) | ácido nucléico isolado, e, composição | |
BR0016066A (pt) | Compostos e métodos para tratamento e diagnóstico de infecção clamidial | |
ITFI920052A1 (it) | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
BR0015137A (pt) | Peptìdeos antigênicos de neisseria | |
WO2002080851A3 (en) | Chimeric vaccines | |
BRPI9912663A (pt) | vacina contra câncer e polipeptídeo. | |
BR0112602A (pt) | Compostos e métodos para tratamento e diagnóstico de infecção clamidial | |
KR910012244A (ko) | 톡소플라스마 곤디 항원, 이의 제조방법 및 이의 용도 | |
DK0661999T3 (da) | Vacciner mod felint immundefekt virus (FIV) | |
Konigsberg et al. | Amino-acid Sequence of the Q β Coat Protein | |
ES2144399T3 (es) | Clonado del adn de virus de anemia de los pollos. | |
GB9409985D0 (en) | Vaccine against mycobacterial infections | |
DK610888D0 (da) | Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse | |
KR950704492A (ko) | 비(b)군 연쇄상구균에 대한 접합 백신(conjugate vaccine against group b streptococcus) | |
PT914437E (pt) | Identificacao e clonagem de um antigenio micobacteriano correspondente a uma hemaglutinina de ligacao a heparina | |
MX9801089A (es) | Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna. | |
KR890013181A (ko) | 플라스모듐 팔시파럼(plasmodium falciparum)의 주위 포자소체 유전자로부터 유도된 재조합 단백질의 제조방법 | |
AU3379693A (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
DE60127113D1 (de) | Gd3 mimetische peptide | |
WO2000021983A3 (en) | Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell | |
BR9815321A (pt) | Vacina de mycoplasma hyopneumoniae recombinante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |